Status | Study |
Completed |
Study Name: Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Condition: Uveitis Anterior Uveitis Intermediate Uveitis Date: 2016-04-25 Interventions: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION Subcutaneous injection twice weekly |
Active, not recruiting |
Study Name: Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis Condition: Posterior Uveitis Intermediate Uveitis Date: 2016-04-19 Interventions: Drug: Sham Injection Drug: FAI Insert |
Active, not recruiting |
Study Name: A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye Condition: Posterior Uveitis Intermediate Uveitis Date: 2016-04-19 Interventions: Drug: FAI insert |
Recruiting |
Study Name: Study of the Effectiveness of Ozurdex for the Control of Uveitis Condition: Uveitis, Intermediate Uveitis, Posterior Date: 2014-01-27 Interventions: Drug: Dexamethasone pellet Dexamethasone pellet placement |
Not yet recruiting |
Study Name: Safety &Efficacy of CF101 to Subjects With Uveitis Condition: Uveitis, Posterior Uveitis, Intermediate Date: 2013-07-14 Interventions: Drug: CF101 CF101 1 mg tablets |
Completed |
Study Name: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis Condition: Uveitis Intermediate Uveitis Posteri Date: 2013-02-05 Interventions: Drug: triamcinolone acetonide (Triesence®) 4 mg of TRIESENCE® (triamcinolone acetonide injecta |
Active, not recruiting |
Study Name: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Condition: Intermediate Uveitis Posterior Uveitis Date: 2012-10-26 Interventions: Drug: Tocilizumab Tocilizumab (4 mg/kg or 8 mg/kg) O |
Active, not recruiting |
Study Name: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Condition: Posterior Uveitis Intermediate Uveitis Date: 2012-09-24 Interventions: Drug: FAI insert Drug: Sham injection |
Recruiting |
Study Name: Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , Condition: Non-infectious Intermediate Uveitis Non-infectious Posterior Uveitis Date: 2012-02-01 Interventions: Drug: LFG316 LFG316 administer |
Terminated |
Study Name: Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Condition: Non-infectious Intermediate and Posterior Uveitis Date: 2011-03-11 Interventions: Drug: Methotrexate 400 μg/100 μL monthly injections for the first 3 months, then as needed per |